Skip to main content

Clinical Trials › NCT05003388

RecruitingPhase 1

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS

Sponsored by The Foundation for Orthopaedics and Regenerative Medicine

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
15
Target enrollment
Jun 2021
Start date
Oct 2025
Expected completion

Interventions / Treatments

AlloRx

Conditions studied

Multiple Sclerosis

Trial locations

U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.

More Phase 1 trials

Browse all Phase 1 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play